2230 · 07/05/2026 16:02:11 · Announcement #95093 · View on Saudi Exchange

The Board of Directors of Saudi Chemical Company Holding Invites its Shareholders to Attend the Extraordinary General Assembly Meeting Via Modern Technology Means (First Meeting).

Element ListExplanation
Introduction The Board of Directors of Saudi Chemical Company Holding is pleased to invite the shareholders to participate and vote in the Extraordinary General Assembly Meeting (First Meeting) on Monday, 22/06/2026, corresponding to 07/01/1448 at 19:00, through a virtual meeting platform Tadawulaty.
City and Location of the General Assembly's Meeting Riyadh – Head Office, Al-Ahsa Street by (Means of Modern Technology)
Hyperlink of the Meeting Location Click Here
Date of the General Assembly's Meeting 2026-06-22 Corresponding to 1448-01-07
Time of the General Assembly’s Meeting 19:00
Methodology of Convening the General Assembly’s Meeting Via modern technology means
Attendance Eligibility, Registration Eligibility, and Voting End The eligibility to attend the Meeting, will be for shareholders registered in the issuer’s shareholders record at the Depositary Center by the end of the trade session prior to the general assembly meeting and in accordance with the laws and regulations. Eligibility for registering the attendance of the Assembly’s meeting ends upon the beginning of the General Assembly’s meeting and eligibility for voting on the Assembly’s Meeting Agenda ends upon the counting committee concludes counting the vote.
Quorum for Convening the General Assembly's Meeting As per the provisions of Article (35) of the Company’s Bylaws, the quorum required for convening the Extraordinary General Assembly Meeting is the attendance of shareholders representing half of the Company’s capital. If the required quorum is not met for the first meeting, a second meeting shall be held one hour after the lapse of the period specified for the first meeting. The second meeting shall be valid if attended by shareholders representing at least one quarter of the Company’s capital.
General Assembly Meeting Agenda • Voting on the amendment of Article No. (17) of the Company’s Bylaws related to the management of the Company (attached).

• Voting on the deletion of Article No. (43) of the Company’s Bylaws related to the Company’s fiscal year (attached).

• Voting on the addition of a new article No. (28) to the Company’s Bylaws related to the Additional Authorities of the Chairman and members of the Board of Directors (attached). Proxy Form The shareholder right in discussing the assembly agenda topics, asking questions, and exercising the voting right Honorable shareholders have the right to discuss the topics included in the agenda of the Extraordinary General Assembly and ask questions and vote on them through the Tadawulaty platform:

www.tadawulaty.com.sa Details of the electronic voting on the Assembly’s agenda All shareholders registered on Tadawulaty shall be able to remotely vote on the agenda items of the Extraordinary General Assembly, which shall commence at 01:00 am on Thursday 18/06/2026 (corresponding to 03/01/1448) up to the end of the meeting. Registration and voting in Tadawulaty services shall be available for all shareholders free of charges through the following link: http://www.tadawulaty.com.sa Method of Communication in Case of Any Enquiries For any inquiries about GA items, please contact the Shareholders Officer through:

Phone: 0114515771 FAX: 0112066349

Or through the following email:

Shareholders.Affairs@saudichemical.com Attached Documents  

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.